Illumina (NASDAQ:ILMN)

buy sell

11 Very Popular Stocks Now Valued Over 50 Times Earnings

2014 has been another great year for stocks, with gains of more than 10% in the Dow Jones Industrial Average and in the S&P 500 Index. That being said, some ...
Read Full Story »
DNA

New Cancer Detection Technique Has Enormous Potential for Life Science Stocks

One of the medical scourges of our era is the increase in cancer cases, not only in the United States, but around the world. One of the most important keys ...
Read Full Story »
biotech

Why Everyone Likes Illumina Again

Illumina Inc. (NASDAQ: ILMN) reported its earnings before the market opened Monday as $0.77 in earnings per share and $481 in revenue which beat out consensus estimates. On the heels ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AmEx, Baidu, BofA, Citi, Lululemon, Netflix, Tiffany and More

Stocks were getting smacked lower again on Thursday morning. While that elusive 10% market correction is closer and closer to fruition, investors still are willing to keep buying value and ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AECOM, Intercept, Kinder Morgan, Rackspace, SunEdison, Disney and More

Stocks were holding on to small gains on Tuesday even after weaker sentiment was reported out of Europe. It looks as though investors have decided they can now shop around ...
Read Full Story »
Biotechnology word cloud

Top Biotech Earnings Previews for the Week Ahead

Earnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector has yet to see any significant earnings representation. That will ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AIG, Intel, eBay, EOG, PetSmart, Time Warner and Many More

Stocks were taking a breather on Thursday after hitting new highs earlier in the week. Many investors still want upside, but they have decided to look for value and unique ...
Read Full Story »
wynn

Credit Suisse Says to Avoid These Crowded Momentum Stocks

The stock market looks wobbly and that may be starting to make many investors nervous. While in the short-term we may be looking at a correction, the long-term prospects for ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Allergan, Galmed, GM, Sirius XM, SunPower and More

Stocks have recovered and are yet again within striking distance of new all-time highs. With earnings season is in full swing, investors want the strong upside stocks but want to ...
Read Full Story »
tesla-model-s-blue

Deutsche Bank Identifies Next S&P 500 Candidates

Typically when stocks are added to the S&P 500, there is a flurry of buying as the stocks are actually inserted into the index and index funds. There is also ...
Read Full Story »
DNA

J.P. Morgan’s Top Biotech and Health Care Picks With Huge Upside

Since March 4, the biotech index is off a massive 19%. There has been plenty of Wall Street speculation on why the sell-off was so violent, but at the end ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Floated the Market

April 16, 2014: Markets opened higher on Wednesday with shares getting a boost in midmorning from the report on crude oil and gasoline stockpiles. The midafternoon release of the Fed’s ...
Read Full Story »
West side view of the United States Capitol building.

Top Biotechnology Stocks On Sale Again

For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from the halls of Congress over drug pricing concerns hit the ...
Read Full Story »
research

Catalysts That Could Push Top Biotech Stocks Even Higher

Despite the hard sell-off in the top biotech names last week, most Wall Street firms remain very positive on the leading stocks. The best thing about the carnage inflicted last ...
Read Full Story »
Monkey evil

Top Analyst Upgrades and Downgrades: Best Buy, Citigroup, EMC, NuSkin, Twitter and More

Earnings season has arrived, and investors and analysts alike are still making many changes to their positions for 2014. Each morning, 24/7 Wall St. reviews dozens of Wall Street analyst research reports. We ...
Read Full Story »